Patents by Inventor Xiaoxi Qiao

Xiaoxi Qiao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8664176
    Abstract: A method is disclosed for treating diseases or disorders of the eye involving undesired neovascularization by administration of a complement inhibitory protein such as soluble complement receptor type I (sCR1). The present invention relates to the direct treatment of macular degeneration, particularly age-related macular degeneration (AMD), by administering a complement inhibitory protein intraocularly or systemically.
    Type: Grant
    Filed: October 19, 2007
    Date of Patent: March 4, 2014
    Assignee: Celldex Therapeutics, Inc.
    Inventors: Henry C. Marsh, Lawrence Thomas, Hua Gao, Xiaoxi Qiao
  • Publication number: 20100130413
    Abstract: A method is disclosed for treating diseases or disorders of the eye involving undesired neovascularization by administration of a complement inhibitory protein such as soluble complement receptor type I (sCR1). The present invention relates to the direct treatment of macular degeneration, particularly age-related macular degeneration (AMD), by administering a complement inhibitory protein intraocularly or systemically.
    Type: Application
    Filed: October 19, 2007
    Publication date: May 27, 2010
    Inventors: Henry C. Marsh, Lawrence Thomas, Hua Gao, Xiaoxi Qiao